Related Experiment Videos

Drosophila von Hippel-Lindau tumor suppressor complex possesses E3 ubiquitin ligase activity

T Aso1, K Yamazaki, T Aigaki

  • 1Department of Viral Oncology, Cancer Institute, Japanese Foundation for Cancer Research, 1-37-1 Kami-ikebukuro, Toshima-ku, Tokyo, 170-8455, Japan. taso@jfcr.or.jp

Insights

The von Hippel-Lindau (VHL) gene

Area of Science:

  • Molecular Biology
  • Genetics
  • Cancer Research

Background:

  • Mutations in the von Hippel-Lindau (VHL) tumor suppressor gene are linked to various human cancers, including renal cell carcinoma and pheochromocytoma.
  • The VHL protein plays a critical role in cellular regulation and tumor suppression.

Purpose of the Study:

  • To identify and characterize the Drosophila homolog of the VHL gene.
  • To investigate the functional conservation of VHL protein in a model organism.

Main Methods:

  • Bioinformatic analysis to identify the Drosophila VHL homolog.
  • Biochemical assays to study protein interactions and enzymatic activity.
  • Ubiquitination assays to identify protein targets.

Main Results:

  • The Drosophila VHL protein shares significant sequence similarity with human VHL.
  • Drosophila VHL forms a complex with Elongins B/C, Cul-2, and Rbx1, exhibiting E3 ubiquitin ligase activity.
  • Hypoxia-inducible factor (HIF)-1alpha is identified as a ubiquitination target for both human and Drosophila VHL complexes.

Conclusions:

  • The functional conservation of VHL and its associated complex in Drosophila provides a valuable model for studying VHL-related diseases.
  • The findings highlight the conserved role of VHL in regulating hypoxia-inducible factors across species.

Related Concept Videos